Implantation or Injectable Dosage Form New Animal Drugs; Guaifenesin Injection
other · Food and Drug Administration · Rule · Published 1998-05-29 · 63 FR 29352
Document
Document number
98-14183
Federal Register citation
63 FR 29352
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1998-05-29
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Phoenix Scientific, Inc. The ANADA provides for intravenous use of guaifenesin injection in horses as a skeletal muscle relaxant.